Harvard Bioscience (HBIO) Reports Q4 Loss of $0.06/Share, Revenue Falls 3.3% to $23.7M
Harvard Bioscience reports Q4 loss of $0.06/share on revenue of $23.7M, down 3.3% year-over-year, with Q1 guidance suggesting continued pressure.
7 articles, transcripts, and reports
Harvard Bioscience reports Q4 loss of $0.06/share on revenue of $23.7M, down 3.3% year-over-year, with Q1 guidance suggesting continued pressure.
Harvard Bioscience Inc (NASDAQ: HBIO) Q2 2022 Earnings Conference
Harvard Bioscience Inc (NASDAQ: HBIO) Q1 2022 Earnings Conference
Harvard Bioscience Inc (NASDAQ: HBIO) Q4 2021 Earnings Conference
Harvard Bioscience Inc (NASDAQ: HBIO) Q3 2021 Earnings Conference
Harvard Bioscience Inc (NASDAQ: HBIO) Q2 2021 Earnings Conference
Harvard Bioscience Inc (NASDAQ: HBIO) Q4 2020 Earnings Conference